Elusiveness of ideal approach to Pseudomonas aeruginosa infection complicating cystic fibrosis.
Marshall
B C
BC
Intermountain Cystic Fibrosis Center, University of Utah Health Sciences Center, Salt Lake City 84132, USA.
Liou
T G
TG
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003550:Cystic Fibrosis / Q000150:complications*; D003718:Denmark; D019468:Disease Management; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D009656:North America; D011552:Pseudomonas Infections / Q000150:complications* / Q000188:drug therapy* / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D006113:United Kingdom
D000900:Anti-Bacterial Agents